TrialAnnals of hematology2019

Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia.

Cornelius F Waller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.